3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
5
Anxiety Disorders
5
Breast Neoplasms
4
Pain
3
Fatigue
2
Depression
2
Vulvar Neoplasms
1
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Rectal Neoplasms
1
Personal Satisfaction
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Myasthenia Gravis
1
Malignant Solid Neoplasm
1
Inflammation
1
Hematopoietic and Lymphatic System Neoplasm
1
Femininity
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cancer Pain
1
Interventions
Temozolomide
2
Radiosurgery
2
Leucovorin
2
Irinotecan
2
Fluorouracil
2
sacubitril and valsartan sodium hydrate drug combination
1
icotinib
1
dostarlimab
1
beta Carotene
1
avelumab
1
alpha-Tocopherol
1
Varenicline
1
Tobacco Use Cessation Devices
1
Therapeutics
1
Thalidomide
1
Radiotherapy
1
Probiotics
1
Panitumumab
1
Nicotine Chewing Gum
1
Myofascial Release Therapy
1
Megestrol Acetate
1
Isotretinoin
1
Folfox protocol
1
Drug Therapy
1
Doxycycline
1
Docetaxel
1
Cryosurgery
1
Clonidine
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms, Second Primary
×
Art Therapy
×
Clear all
NCT04195217
2021-12-17
ARONCO
Centre Hospitalier de Perigueux
Phase NA
Unknown
86 enrolled